Mount Sinai Appoints Chair of Department of Medicine and New Chief of Pediatric Hematology Oncology
Mark W. Babyatsky, MD, has been appointed Chair of the Department of Medicine at The Mount Sinai Medical Center; and Robert Maki, MD, PhD, has been appointed as the Chief of the Pediatric Hematology/Oncology Division and Medical Director of the Sarcoma Cancer Program in The Tisch Cancer Institute.
Dr. Babyatsky succeeds Paul Klotman, MD, who is now President and Chief Executive Officer of Baylor College of Medicine in Houston, Texas. During his 16-year tenure at Mount Sinai, Dr. Babyatsky has served as Program Director of the Internal Medicine Residency Program and as Vice Chair of Education for the Department of Medicine. In his new role, Dr. Babyatsky will work closely with Mount Sinai's translational research institutes toward making Mt. Sinai a leader in improving primary care under the new Affordable Care Act.
Dr. Babyatsky's research has focused on the role of somatostatin in Inflammatory Bowel Disease. He has earned several awards and honors for his work, including a Crohn's and Colitis Foundation of America First Award and the Solomon Silver Award from Mount Sinai School of Medicine. He is a member of the American College of Physicians. Dr. Babyatsky is also a recognized leader in medical genomics and is co-authoring the first textbook on the subject. He earned his MD at Albert Einstein College of Medicine. He completed a fellowship at Massachusetts General Hospital and residency in internal medicine at Mount Sinai School of Medicine.
Dr. Maki joins The Mount Sinai Medical Center and The Tisch Cancer Institute from Weill Cornell Medical College, where he was serving as an associate professor of medicine and co-director of the Adult Sarcoma Program at Memorial Sloan-Kettering Cancer Center. A renowned sarcoma cancer researcher, Dr. Maki is a leader in soft-tissue and bone sarcoma research. …